Carboplatin Combined With Paclitaxel in Treating Patients With Advanced Thymoma
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one chemotherapy drug may kill more tumor
cells.
PURPOSE: Phase II trial to study the effectiveness of carboplatin combined with paclitaxel in
treating patients who have advanced thymoma.